Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Rodeck

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Journal of Cell Science|January 1, 1997
EGF-R dependent regulation of keratinocyte survivalU Rodeck, M Jost, C Kari, et al.
The American Journal of Pathology|August 6, 1999
Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patientsG Bellone, A Turletti, E Artusio, et al.
Gene Therapy|April 5, 2013
Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccineO Igoucheva, M Grazzini, A Pidich, et al.
The Journal of Pathology|January 1, 1997
WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosisS Kumar-Singh, K Segers, U Rodeck, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alphaK Adachi, P Belser, H Bender, et al.
American Journal of Clinical Oncology|August 1, 1992
Radiotoxicity of 125I-labeled monoclonal antibody 425 against cancer cells containing epidermal growth factor receptorL Derui, D V Woo, J Emrich, et al.
Journal of Cellular Physiology|July 1, 1997
Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1G Bellone, S Silvestri, E Artusio, et al.
Journal of the National Cancer Institute|March 15, 1989
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosidesD Iliopoulos, C Ernst, Z Steplewski, et al.
The Journal of Investigative Dermatology|February 1, 1988
Growth and phenotypic characteristics of human nevus cells in cultureM L Mancianti, M Herlyn, D Weil, et al.
Hybridoma|June 17, 1998
Characterization of monoclonal antibodies directed to the amino-terminus of the WT1, Wilms' tumor suppressor proteinF J Rauscher, J F Morris, W J Fredericks, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Journal of Cell Science|January 1, 1997
EGF-R dependent regulation of keratinocyte survivalU Rodeck, M Jost, C Kari, et al.
The American Journal of Pathology|August 6, 1999
Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patientsG Bellone, A Turletti, E Artusio, et al.
Gene Therapy|April 5, 2013
Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccineO Igoucheva, M Grazzini, A Pidich, et al.
The Journal of Pathology|January 1, 1997
WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosisS Kumar-Singh, K Segers, U Rodeck, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alphaK Adachi, P Belser, H Bender, et al.
American Journal of Clinical Oncology|August 1, 1992
Radiotoxicity of 125I-labeled monoclonal antibody 425 against cancer cells containing epidermal growth factor receptorL Derui, D V Woo, J Emrich, et al.
Journal of Cellular Physiology|July 1, 1997
Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1G Bellone, S Silvestri, E Artusio, et al.
Journal of the National Cancer Institute|March 15, 1989
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosidesD Iliopoulos, C Ernst, Z Steplewski, et al.
The Journal of Investigative Dermatology|February 1, 1988
Growth and phenotypic characteristics of human nevus cells in cultureM L Mancianti, M Herlyn, D Weil, et al.
Hybridoma|June 17, 1998
Characterization of monoclonal antibodies directed to the amino-terminus of the WT1, Wilms' tumor suppressor proteinF J Rauscher, J F Morris, W J Fredericks, et al.
Pageof 9